CI: Cigna Group (The) Stock

SIC 6324 – Hospital and Medical Service Plans

Valuation
Market Cap ($M) 76,003.66
Enterprise Value ($M) 100,601.66
Book Value ($M) 44,596.00
Book Value / Share 150.73
Price / Book 1.70
NCAV ($M) -71,459.00
NCAV / Share -241.52
Price / NCAV -1.06

Profitability (mra)
Return on Invested Capital (ROIC) 0.09
Return on Assets (ROA) 0.04
Return on Equity (ROE) 0.15

Liquidity (mrq)
Quick Ratio 0.62
Current Ratio 0.71

Balance Sheet (mrq) ($M)
Current Assets 31,921.00
Assets 147,976.00
Liabilities 103,380.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 180,021.00
Operating Income 8,048.00
Net Income 6,668.00
Earnings Per Share Diluted n/a
Earnings Per Share Effect Of Dilution n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 8,656.00
Cash from Investing 3,098.00
Cash from Financing -11,240.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/ 4.50 -23.97
02-14 13G/A Dodge & Cox 3.80 -33.95
02-09 13G/A Vanguard Group Inc 8.37 -2.06
02-09 13G Fmr Llc 5.32 3.37
02-07 13G BlackRock Inc. 9.00 -7.16

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-05-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO
2023-02-23 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2022-11-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT
2022-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2023-06-02 180,594 1,282,815 14.08
2023-06-01 266,619 1,966,476 13.56
2023-05-31 320,495 4,134,890 7.75
2023-05-30 196,840 1,475,375 13.34

(click for more detail)

Similar Companies
AFL – Aflac Inc. ANTM – Anthem Inc
BHG – Bright Health Group Inc CNC – Centene Corp.
CNO – CNO Financial Group Inc


Financial data and stock pages provided by
Fintel.io